However, in a recent report, blood plasma from COVID-19 patients was able to block the expression of HLA-DR on CD14+ monocytes, which was restored effectively on inhibiting IL-6, suggesting that decreased HLA-DR expression in SARS-CoV-2 patients is due to the buildup of hyper-inflammatory conditions (78). The gene discussed is IL6; the disease is COVID-19.